ArticleHistopathology2026

Pathologic assessment of resected stage III non-small cell lung cancer after neoadjuvant chemotherapy: identification of additional prognostic factors.

Francesca Lunardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.